Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/131691
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Arming androgen receptors to oppose oncogenic estrogen receptor activity in breast cancer
Author: Hickey, T.E.
Dwyer, A.R.
Tilley, W.D.
Citation: British Journal of Cancer, 2021; 125(12):1599-1601
Publisher: Springer Nature
Issue Date: 2021
ISSN: 0007-0920
1532-1827
Statement of
Responsibility: 
Theresa E. Hickey, Amy R. Dwyer and Wayne D. Tilley
Abstract: Most breast cancers are driven by oncogenic activity of the estrogen receptor alpha (ER). Resistance to ER target therapies is the major cause of breast cancer death. Recently, there has been renewed interest in targeting the androgen receptor (AR) to treat ER-driven breast cancers. Herein, we discuss evidence for an AR agonist, not antagonist, treatment strategy.
Keywords: Humans
Breast Neoplasms
Receptors, Androgen
Receptors, Estrogen
Female
Description: Published online: 22 July 2021
Rights: © The Author(s), under exclusive licence to Springer Nature Limited 2021. Published on Behalf of CRUK
DOI: 10.1038/s41416-021-01478-8
Grant ID: http://purl.org/au-research/grants/nhmrc/1084416
http://purl.org/au-research/grants/nhmrc/1130077
Published version: http://dx.doi.org/10.1038/s41416-021-01478-8
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.